China has reported its first major coronavirus outbreak in about two months, with its origins tracing back to a wholesale food market in Beijing. The capital city has issued lockdown measures to contain the virus's resurgence in its origin country, providing a glimpse into the continued containment effort nations around the world will need to take as they press towards some social normalcy. Currently, China has over 83,181 confirmed cases and 4,634 reported deaths, according to the Associated Press.

The World Health Organization stated during a press conference on Monday that more scientists globally need to investigate emerging disease clusters of COVID-19 to find what is driving infection and causing further spread.

"The answers lie in careful, systematic, exhaustive investigation of disease clusters to really look at what is happening in these situations and what is causing the amplification of the disease in the human context," W.H.O. Executive Director of Emergencies Dr. Mike Ryan stated. "If we get that, we will build up a much better picture of the public health advice we need to give to our communities on what behaviors to avoid, what places to avoid, and what circumstances to avoid."

Meanwhile, borders across Europe have begun to reopen ahead of the summer tourism season. The continent's nations had closed their borders back in March in a hasty effort to control the initial coronavirus outbreak. While this is a great first step for the countries in terms of recovery, the nations aren't expects to welcome visitors from outside of Europe at least until next month, or possibly longer.

Total Global Cases: Over 8.1 Million

Total Deaths: Over 439,000

Total Recovered: Over 4.2 Million

Medicine Check-up

The U.S. Food and Drug Administration on Monday retracted its emergency use authorization for the anti-malaria drugs hydroxychloroquine and chloroquine as a treatment for COVID-19. The agency determined that the drugs were "unlikely to be effective in treating COVID-19," and adding," in light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer outweigh the know and potential risks for the authorized use."

The F.D.A. also warned on Monday that the two drugs in combination with Gilead Sciences's (GILD  ) remdesivir have shown to interfere with the latter's effectiveness in treating COVID-19. Currently, remdesivir is the only drug that has shown positively treat the coronavirus to some capacity. Remdesivir was given emergency use authorization by the F.D.A. for the treatment of hospitalized patients with severe disease.

For vaccine news, AstraZeneca (AZN  ) reached an agreement over the weekend with Europes's Inclusive Vaccine Alliances to supply up to 400 million doses of the potential coronavirus vaccine being developed by researchers at the University of Oxford. The company disclosed that it is building a number of supply chains across the world to bring its total manufacturing capacity up to 2 billion doses.